ArchiMed acquires majority stake in Xpress Biologics
ArchiMed has acquired Xpress Biologics, a Belgian provider of plasmid DNA for advanced therapy medicinal products.
5 October 2021•4 mins read
ArchiMed has acquired Xpress Biologics, a Belgian provider of plasmid DNA for advanced therapy medicinal products.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
16 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
16 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
16 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
16 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
17 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
17 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
19 hours ago · 3 mins read
